BlackRock Inc. - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 129 filers reported holding ANIKA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$26,382,594
-58.7%
1,416,135
-42.4%
0.00%
-50.0%
Q2 2023$63,862,295
-9.5%
2,458,133
+0.1%
0.00%0.0%
Q1 2023$70,558,491
-5.7%
2,456,772
-2.8%
0.00%0.0%
Q4 2022$74,793,338
+27.8%
2,526,802
+2.7%
0.00%0.0%
Q3 2022$58,527,000
+8.8%
2,459,181
+2.1%
0.00%0.0%
Q2 2022$53,773,000
-10.2%
2,409,187
+1.0%
0.00%0.0%
Q1 2022$59,900,000
-29.1%
2,385,545
+1.1%
0.00%0.0%
Q4 2021$84,510,000
-14.1%
2,358,617
+2.0%
0.00%
-33.3%
Q3 2021$98,388,000
-3.5%
2,311,780
-1.9%
0.00%0.0%
Q2 2021$101,989,000
+6.0%
2,355,935
-0.1%
0.00%0.0%
Q1 2021$96,231,000
-5.5%
2,359,190
+4.8%
0.00%0.0%
Q4 2020$101,849,000
+34.4%
2,250,290
+5.1%
0.00%0.0%
Q3 2020$75,787,000
-5.6%
2,141,417
+0.7%
0.00%0.0%
Q2 2020$80,272,000
+32.7%
2,127,532
+1.7%
0.00%0.0%
Q1 2020$60,486,000
-45.2%
2,092,198
-1.6%
0.00%
-25.0%
Q4 2019$110,297,000
-3.7%
2,127,249
+1.9%
0.00%
-20.0%
Q3 2019$114,577,000
+30.6%
2,087,398
-3.4%
0.01%
+25.0%
Q2 2019$87,737,000
+36.5%
2,159,985
+1.6%
0.00%
+33.3%
Q1 2019$64,294,000
-9.5%
2,126,117
+0.6%
0.00%
-25.0%
Q4 2018$71,020,000
-21.2%
2,113,049
-1.1%
0.00%0.0%
Q3 2018$90,112,000
+36.8%
2,136,362
+3.8%
0.00%
+33.3%
Q2 2018$65,851,000
-30.7%
2,057,830
+7.7%
0.00%
-40.0%
Q1 2018$94,976,000
-6.1%
1,910,203
+1.8%
0.01%0.0%
Q4 2017$101,171,000
-4.1%
1,876,645
+3.2%
0.01%0.0%
Q3 2017$105,473,000
+19.7%
1,818,525
+1.9%
0.01%0.0%
Q2 2017$88,097,000
+13.5%
1,785,481
-0.1%
0.01%
+25.0%
Q1 2017$77,650,000
+87147.2%
1,787,525
+97900.3%
0.00%
Q4 2016$89,000
-7.3%
1,824
-8.5%
0.00%
Q3 2016$96,000
-11.9%
1,993
-1.9%
0.00%
Q2 2016$109,000
+142.2%
2,032
+99.0%
0.00%
Q1 2016$45,000
+40.6%
1,021
+22.3%
0.00%
Q4 2015$32,000
-15.8%
835
-29.9%
0.00%
Q3 2015$38,000
+280.0%
1,191
+309.3%
0.00%
Q2 2015$10,000
-28.6%
291
-12.1%
0.00%
Q1 2015$14,000
+7.7%
3310.0%0.00%
Q4 2014$13,000
+8.3%
3310.0%0.00%
Q3 2014$12,000
-20.0%
3310.0%0.00%
Q2 2014$15,000
+25.0%
331
+8.9%
0.00%
Q1 2014$12,0000.0%3040.0%0.00%
Q4 2013$12,000
+50.0%
304
-14.1%
0.00%
Q3 2013$8,000
+33.3%
3540.0%0.00%
Q2 2013$6,0003540.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders